Chronic Obstructive Pulmonary Disease and Emphysema: Treatment & Medication - eMedicine Emergency Medicine
Links shared publicly online about this topic.
- 1,356total visits
Chronic Obstructive Pulmonary Disease and Emphysema: Treatment & Medication - eMedicine Emergency Medicine
View full resource at emedicine.medscape.com
Tags: Emergency, COPD, Disease and Condition, Drug, Antibiotic, Doryx, Pulmonology, Emphysema
Most Recently Shared on February 25, 2010 at 3:31 pm By:
New study finds doxycycline plus corticosteroids successfully treat COPD exacerbations. See COPD and Emphysema article http://bit.ly/cMMUJM
Novartis launches Arcapta Neohaler, a novel once-daily bronchodilator for chronic obstructive pulmonary disease - Drugs.com MedNews
drugs.com — “- Arcapta Neohaler is the only once-daily, 24-hour long-acting beta2-agonist approved for maintenance treatment of airflow obstruction in COPD patients Novartis” View full resource at drugs.com
Most Recently Shared on March 20, 2012 at 12:07 pm By:
Drugs and Devices OW OW Health
Novartis launches Arcapta Neohaler, a novel once-daily bronchodilator for chronic obstructive pulmonary di... http://t.co/fZkiPS6X #drug
ingentaconnect Cost Effectiveness of Pharmacological Maintenance Treatment for C...
ingentaconnect.com — “ingentaconnect Cost Effectiveness of Pharmacological Maintenance Treatment for C...” View full resource at ingentaconnect.com
Most Recently Shared on March 16, 2012 at 1:42 pm By:
OrganizedWisdom COPD OW Health
Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease: A Review ... http://t.co/0go8bCsE
U.S. panel backs Forest Labs drug for smoker's cough - Yahoo! News
news.yahoo.com — “From Yahoo! News: SILVER SPRING, Maryland (Reuters) - An experimental inhaled lung treatment from Forest Laboratories Inc and Almirall SA won the support of a U.S. advisory panel on Thursday, a boost toward eventually gaining approval for the drug to treat smoker's cough. A panel of outside expert advisers to the Food and Drug Administration voted 12-2 to recommend approval of the twice-daily drug, known generically as aclidinium bromide. The drug treats chronic obstructive pulmonary disease (CO” View full resource at news.yahoo.com
Most Recently Shared on February 24, 2012 at 5:38 am By:
U.S. panel backs Forest Labs drug for smoker's cough: SILVER SPRING, Maryland (Reuters) - An experimental inhale... http://t.co/4hFANp2T
New once-daily beta-agonist improves lung function in COPD - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – An investigational long-acting beta-2-agonist, vilanterol, inhaled once-daily improves FEV1 significantly in patients with moderate-to-severe chronic obstructive pulmonary disease after a month of treatment, according to a report in Chest online January...” View full resource at thedoctorschannel.com
Most Recently Shared on January 24, 2012 at 11:23 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
What are your thoughts of vilanterol used to treat FEV1? - From Reuters Health/TDC http://t.co/ECSgdWaq #pulmonary #health
Vitamin D Doesn't Help Chronic Obstructive Pulmonary Disease
medicalnewstoday.com — “Chronic Obstructive Pulmonary Disease (COPD) is characterized by diseases such as Bronchitis and Emphysema, where breathing becomes more difficult as the airways are inflamed, blocked with mucus” View full resource at medicalnewstoday.com
Most Recently Shared on January 18, 2012 at 5:05 pm By:
Vitamin D Doesn't Help Chronic Obstructive Pulmonary Disease http://t.co/9sPFWy2U #healthnews
Lung Volume Reduction Surgery (LVRS) for COPD at Columbia Univeristy Medical Center
columbiasurgery.org — “Lung Volume Reduction Surgery (LVRS), involving removal of sections of damaged lung tissue, has shown promising results for patients with end-stage emphysema. By removing the most diseased tissue (up to 30% of the lung volume), the goal is to improve the residual lung function and respiratory mechanics. LVRS can be performed through either median sternotomy (open chest) or video-assisted minimally invasive technique.” View full resource at columbiasurgery.org
Most Recently Shared on December 2, 2011 at 8:00 pm By:
What is lung volume reduction surgery and how is this used to treat chronic obstructive pulmonary disease? http://t.co/lUHqEoOD
New COPD Treatments Needed, Expert Says : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on November 28, 2011 at 9:33 pm By:
Bob Finn - Medical News Net Health News
Current treatments for chronic obstructive pulmonary disease can leave many patients with unmet needs - http://t.co/baaJ0Ez5
COPD Alliance | Breathing new life into the recognition and management of COPD
copd.org — “Nearly 12 million Americans with COPD remain undiagnosed.As a multidisciplinary alliance, our mission is to bring clinicians together to improve patients’ quality of life through recognition and management of chronic obstructive pulmonary disease (COPD).” View full resource at copd.org
Most Recently Shared on November 8, 2011 at 2:05 pm By:
@COPDAlliance is encouraging clinicians to become “COPD Prepared” during COPD Awareness Month. http://t.co/Ukb6aGKq
NIPPV helps decrease mortality rates among hospitalized COPD patients
news-medical.net — “Although increased use of noninvasive positive-pressure ventilation (NIPPV) nationwide has helped decrease mortality rates among patients hospitalized with chronic obstructive pulmonary disease (COPD), a small group of patients requiring subsequent treatment with invasive mechanical ventilation (IMV) have a significantly higher risk of death than those placed directly on IMV, according to researchers in the United States who studied patterns of NIPPV use.” View full resource at news-medical.net
Most Recently Shared on October 22, 2011 at 10:11 am By:
OrganizedWisdom COPD OW Health
NIPPV helps decrease mortality rates among hospitalized COPD patients: Although increased use of noninvasive pos... http://t.co/BEy2jX6f
NIPPV linked to increased hospital mortality rates in small group of patients
eurekalert.org — “Although increased use of noninvasive positive-pressure ventilation (NIPPV) nationwide has helped decrease mortality rates among patients hospitalized with chronic obstructive pulmonary disease (COPD), a small group of patients requiring subsequent treatment with invasive mechanical ventilation (IMV) have a significantly higher risk of death than those placed directly on IMV, according to researchers in the United States who studied patterns of NIPPV use.” View full resource at eurekalert.org
Most Recently Shared on October 21, 2011 at 11:20 pm By:
OrganizedWisdom COPD OW Health
NIPPV linked to increased hospital mortality rates in small group of patients: (American Thoracic Society) Altho... http://t.co/OSihdS1Y
Kissei Pharmaceutical to support MN-221 development programme - Pharmaceutical Technology
pharmaceutical-technology.com — “Japan's Kissei Pharmaceutical said it will pay MediciNova $2.5m to support further clinical development of MN-221 for the treatment of acute exacerbations of asthma or chronic obstructive pulmonary disease (COPD).MN-221 is a novel, highly...” View full resource at pharmaceutical-technology.com
Most Recently Shared on October 19, 2011 at 10:31 pm By:
OrganizedWisdom COPD OW Health
Kissei Pharmaceutical to support MN-221 development programme: Japan's Kissei Pharmaceutical said it will pay Me... http://t.co/rfWxUWyd
Researchers Discover Why Steroid Treatment For COPD Is Ineffective
medicalnewstoday.com — “Chronic obstructive pulmonary disease (COPD) leads to persistent inflammation of the airways and is typically managed with corticosteroids, a class of anti-inflammatory medication. However, cortic” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2011 at 9:05 am By:
Researchers Discover Why Steroid Treatment For COPD Is Ineffective http://t.co/pOHmbyiZ #asthma
Potential To Reverse Smoke-Induced Damage And Disease In The Lungs
medicalnewstoday.com — “By studying mice exposed to tobacco smoke for a period of months, researchers have new insight into how emphysema and chronic obstructive pulmonary disease (COPD) develops. In Cell, a Cell” View full resource at medicalnewstoday.com
Most Recently Shared on October 14, 2011 at 9:06 am By:
Potential To Reverse Smoke-Induced Damage And Disease In The Lungs: By studying mice exposed to tobacco smoke fo... http://t.co/MyS9rEjx
FDA Approves Combivent Respimat (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
drugs.com — “Combivent Respimat (albuterol and ipratropium bromide) is used to treat chronic obstructive pulmonary disease. Includes Combivent Respimat side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 11, 2011 at 12:07 am By:
FDA Approves Combivent Respimat (ipratropium bromide and albuterol) Inhalation Spray for COPD - http://t.co/3UJWkUpF
Combivent Respimat Inhalation Spray Approved for COPD - MPR
empr.com — “Boehringer Ingelheim announced that the FDA has approved Combivent Respimat (ipratropium bromide and albuterol), a propellant-free metered dose inhalation spray that uses a slow-moving mist, for the treatment of chronic obstructive pulmonary disease (COPD).” View full resource at empr.com
Most Recently Shared on October 10, 2011 at 3:15 pm By:
Combivent Respimat Inhalation Spray Approved for #COPD http://ow.ly/6SDtO
Advertisement
